Selected References:
- Novo Nordisk. 2022. Ozempic Product Label. National Institute of Health DailyMed database. Available at https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=adec4fd2-6858-4c99-91d4-531f5f2a2d79. Accessed 24 Sept 2023.
- Skov K, et al. 2023. Semaglutide and pregnancy. Int J Gynecol Obstet 163(2): 699-700.
- S. Food and Drug Administration (FDA). 2023. Medications Containing Semaglutide Marketed for Type 2 Diabetes or Weight Loss. Postmarket Drug Safety Information for Patients and Providers. Available at https://www.fda.gov/drugs/postmarket-drug-safety-information-patients-and-providers/medications-containing-semaglutide-marketed-type-2-diabetes-or-weight-loss. Accessed 24 Sept 2023.
- S. Food and Drug Administration (FDA). 2017. Ozempic (Semaglutide). Center for Drug Evaluation and Research.
